(Q36383595)

13 August 2017

1 reference

title

Use of methylphenidate in patients with cancer (English)

1 reference

13 August 2017

Amit Sood

1

1 reference

PubMed ID

16450661

13 August 2017

Debra L Barton

series ordinal

2

1 reference

PubMed ID

16450661

13 August 2017

Charles L Loprinzi

series ordinal

3

1 reference

13 August 2017

1 January 2006

1 reference

American Journal of Hospice and Palliative Medicine

13 August 2017

1 reference

13 August 2017

23

1 reference

13 August 2017

35-40

1 reference

13 August 2017

1

1 reference

Drug Therapy for Adults with Attention-Deficit Hyperactivity Disorder

13 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

Enantioselective pharmacokinetics and pharmacodynamics of dl-threo-methylphenidate in children with attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

Use of stimulants in the medically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

Cocaine and other stimulants. Actions, abuse, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

Failed attempts at intranasal abuse of Concerta

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

A phase II study of methylphenidate for depression in advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

Psychostimulants for depression in hospitalized cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

Dextroamphetamine or methylphenidate as adjuvants to opioid analgesia for adolescents with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

Methylphenidate therapy improves cognition, mood, and function of brain tumor patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

Methylphenidate in neuropsychological sequelae of radiotherapy and chemotherapy of childhood brain tumors and leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

Methylphenidate in the treatment of neurobehavioral slowing associated with cancer and cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

Cancer-related fatigue: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

Palliative uses of methylphenidate in patients with cancer: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910602300106

10.1177/104990910602300106

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16450661